Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 2,816 AGIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,816 | n/a |
| Jun 22, 2026 | Editas Medicine, Inc. (EDIT) | Grant/Award | 51,700 | n/a |
| Nov 14, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 200 | $3.6K |
| Oct 10, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 200 | $3.6K |
| Oct 2, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 200 | $3.6K |
| Aug 29, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 200 | $3.6K |
| Jul 15, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 1,400 | $25.3K |
| Jun 23, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,120 | n/a |
| Jun 10, 2025 | Editas Medicine, Inc. (EDIT) | Grant/Award | 37,500 | n/a |
| Dec 13, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 200 | $3.6K |